Many different theories have been advanced concerning the biological roles of the oligosaccharide units of individual classes of glycoconjugates. Analysis of the evidence indicates that while all of these theories are correct, exceptions to each can also be found. The biological roles of oligosaccharides appear to span the spectrum from those that are trivial, to those that are crucial for the development, growth, function or survival of an organism. Some general principles emerge. First, it is difficult to predict a priori the functions a given oligosaccharide on a given glycoconjugate might be mediating, or their relative importance to the organism. Second, the same oligosaccharide sequence may mediate different functions at different locations within the same organism, or at different times In its ontogeny or life cycle. Third, the more specific and crucial biological roles of oligosaccharides are often mediated by unusual oligosaccharide sequences, unusual presentations of common-terminal sequences, or by further modifications of the sugars themselves. However, such oligosaccharide sequences are also more likely to be targets for recognition by pathogenic toxins and microorganisms. As such, they are subject to more intra-and inter-species variation because of ongoing host-pathogen interactions during evolution. In the final analysis, the only common features of the varied functions of oligosaccharides are that they either mediate 'specific recognition' events or that they provide 'modulation' of biological processes. In so doing, they generate much of the functional diversity required for the development and differentiation of complex organisms, and for their interactions with other organisms in the environment.
Introduction
The ability to accurately sequence the oligosaccharide units of glycoconjugates has revealed a remarkable complexity and diversity of these molecules (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . However, despite some observations suggesting important biological roles for these sugar chains, a single common theory has not emerged to explain this diversity. As recently as 1988, it was stated that while '. . . the functions of DNA and proteins are generally known ... it is much less clear what carbohydrates do ' (12) . A variety of theories have been advanced regarding the biological roles of the oligosaccharides, and have been presented © Oxford University Press in a number of monographs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) and review articles . These include a purely structural role, an aid in the conformation and stability of proteins, the provision of target structures for microorganisms, toxins and antibodies, the masking of such target structures, control of the half-life of proteins and cells, the modulation of protein functions, and the provision of ligands for specific binding events mediating protein targeting, cell-matrix interactions or cell-cell interactions. Most of these discussions have focused either on one specific type of glycoconjugate (e.g. glycoprotein, proteoglycan or glycolipid) or on one specific theory of function. In this overview, an attempt is made to consider together all of these theories regarding all of the major types of glycoconjugates. Although the emphasis of diis review is somewhat biased towards the glycoprotein oligosaccharides of higher animal cells, the principles that emerge appear to be generally applicable to glycoconjugates in all types of organisms.
Because of the broad and diverse nature of the subjects discussed here, a comprehensive bibliography has not been presented. In general, the original references are from the last 15 years, with a very limited representation of earlier citations. For detailed discussions of the classic and original literature on some of these matters, the interested reader is referred to the list of monographs (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ) and reviews provided.
The difficulty in predicting specific rules for oligosaccharide functions: N-and 0-linked sugar chains as examples
Of all of the different types of glycosylation, the //-asparaginelinked sugar chains are the easiest to manipulate in experimental systems. Feasible approaches include the enzymatic or chemical removal of completed sugar chains, prevention of initial glycosylation, alteration of oligosaccharide processing, elimination of specific glycosylation sites, and the study of natural variants and genetic mutants in glycosylation. Such approaches have been used extensively to explore the biological roles of these sugar chains on a variety of glycoproteins (reviewed in 5, 8, 9, 12, 15-17, 20-36, 107-115, 126-131) . A summary of many such studies is reported in Table I and a shorter list of similar experiments for O-linked oligosaccharides is presented in Table II . It can be seen that the consequences of altering these types of glycosylation range from being essentially undetectable, to the complete loss of particular functions, or even loss of the entire protein itself. Even within a given group of proteins (e.g. cell surface receptors or enzymes), the effects of altering glycosylation are highly variable and quite unpredictable. Furthermore, the same modification in glycosylation can have a dramatically opposite effect on in vivo function versus that observed for in vitro function (for example, see the studies on erythropoietin and the gonadotrophic hormones referred to in Table I ). These facts underscore a basic principle about the biological roles of oligosaccharides: they appear to range from trivial to crucial, depending on the glycoconjugate, the oligosaccharide structure, the biological context and the question being asked.
Can one make any sense out of these diverse and confusing findings? Most prior attempts to approach this issue have focused on either a single type of glycosylation or on a single theory of their function. In the following pages, an attempt is made to undertake a global overview of most of the known facts concerning the biological roles of oligosaccharides of major classes of glycoconjugates in eukaryotic cells, and to synthesize some general principles for understanding them. Much of the actual data is presented in table form and is necessarily simplified and/or incomplete. For more details, the interested reader is referred to the original literature cited in these tables, and to the monographs and reviews mentioned earlier.
'Structural', 'protective' and 'stabilizing' roles of oligosaccharides
There is little doubt that some oligosaccharides, such as those of the proteoglycans and the collagens, are important in the physical maintenance of tissue structure, integrity and porosity (see Table HI ). It is also clear that the 'coating' of oligosaccharides on many glycoproteins can serve to protect the polypeptide chain from recognition by proteases or antibodies (see Tables I, n and HI) and that the coating of glycoconjugates covering a whole cell can present a 'glycocalyx' of substantial proportions. Another well-accepted function of the oligosaccharide units of glycoproteins is that they are involved in the initiation of correct polypeptide folding in the rough endoplasmic reticulum (ER), and in the subsequent maintenance of protein solubility and conformation (see examples in Tables I  and II) . Thus, many proteins that are incorrectly glycosylated fail to fold properly and/or fail to exit the ER, and are consequently degraded. On the other hand, there are many examples of proteins for which the prevention or alteration of glycosylation has little apparent consequence to their synthesis, folding, or delivery to a final location (see Tables I and IT) . Likewise, there are examples wherein removal of the oligosaccharides from a mature protein does not drastically alter sensitivity to proteolysis or immune recognition, nor their functions. These apparently contradictory observations exemplify a recurring theme: that while supporting evidence can be found for many theories regarding oligosaccharide function, exceptions to each can equally well be observed.
In general, the development of these 'structural', 'protective' and 'stabilizing' functions during evolution should not have required the enormous complexities of structure that are found in naturally occurring oligosaccharide units. In keeping with this, inhibitors that only affect the later processing steps of oligosaccharide biosynthesis generally do not interfere with these types of functions. In these situations then, the oligosaccharides are analogous to the 'axle grease' of an automobile. While its absence would markedly affect the ability of the entire vehicle to function, the fine details of the composition of the grease should not be critical to the turning of the axle. Thus, while these roles of oligosaccharides are vital to the basic structure and function of the organism, they cannot explain the extensive structural diversity seen in nature.
The 'organizational' and 'barrier' functions
The extracellular matrix consists of a variety of glycoconjugates, each of which have been shown to have binding sites for various types of sugar chains, e.g. the heparin-binding domains of fibronectin and collagen. Recently, the role of such oligosaccharide-binding domains in the organization of the matrix has been clearly demonstrated in vitro (see Table HI ). Thus, for example, the chondroitin sulphate chain of the proteoglycan decorin is required for the organization of fibronectin in the extracellular matrix of Chinese hamster ovary (CHO) cells, which in turn dictates the phenotype of the cells in culture. In another case, the /3-galactoside-binding function ' of a soluble lectin appears to be involved in the organization of elastin in the extracellular matrix. Similar functions have been proposed for the interaction between the polylactosamine chains of laminin oligosaccharides and certain j3-galactoside-binding lectins. As shown in the other examples in Table m , oligosaccharides may also serve to create charge effects and domains in membranes.
Oligosaccharides as specific receptors for noxious agents: the 'traitorous' functions It is abundantly clear that certain oligosaccharides can act as highly specific receptors for a variety of viruses, bacteria and parasites (see Table IV ). They are also receptors for many plant and bacterial toxins, and serve as antigens for autoimmune and alloimmune reactions. In most of these instances, there is exquisite specificity for the sequence of the oligosaccharide involved. Thus, for example, the influenza viral haemagglutinins specifically recognize the type of sialic acid, its modifications and its linkage to the underlying sugar chain, while cholera toxin binds with great specificity to G M ] ganglioside and not to related structures. Likewise, incompletely synthesized (or partially degraded) oligosaccharides such as the Tn antigen can behave as autoantigens in man. There is little doubt about the extreme specificity of this group of 'functions' of oligosaccharides (see Table IV ). In fact, this specificity has been used to great advantage by scientists investigating the expression of these sugar chains. However, to the organism that synthesized such oligosaccharides, there is little value in providing such 'traitorous' signposts to aid the access of 102 pathogenic microorganisms or to permit damaging autoimmune reactions.
Oligosaccharide sequences that protect from microorganisms and antibodies: the 'masking' and 'decoy' functions Just as certain oligosaccharides act as 'traitorous' signposts for microbial and immune attack, others can serve to abrogate these detrimental reactions (see Table V ). In these cases, the addition of specific monosaccharides or modifications masks the sequences recognized by microorganisms, toxins or autoimmune antibodies. Thus, for example, the addition of a single C*-acetylester to the 9-position of terminal sialic acid residues abrogates binding of the highly pathogenic influenza A viruses, and the extension of the oligosaccharide chain of GM! would prevent binding of cholera toxin. Likewise, the addition of galactose and sialic acid to the Tn antigen would abolish its autoimmune reactivity. Oligosaccharide sequences on soluble glycoconjugates such as the mucins can also act as 'decoys' for microorganisms and parasites. Thus, pathogenic organisms attempting to gain access to mucosal membranes might first encounter their cognate oligosaccharide ligands attached to soluble mucins. Upon binding to these sequences, they could then be swept away by ciliary action, leaving me mucosal cells untouched. In these cases, the host may successfully turn the specificity of the pathogen receptor to its own advantage.
Oligosaccharides as specific receptors for 'symbiotic' functions
The possible evolutionary interplay between the 'traitorous' and 'masking' functions of oligosaccharides is discussed below. In contrast to these functions of sugar chains, there are some cases in which symbiotic relationships of animals with microorganisms appear to be aided by interactions involving specific oligosaccharides. Thus, certain commensal gut bacteria in animals and some root nodule-forming bacteria in plants appear to mediate their binding to host cell surfaces via specific sugar sequences, hi these cases, inter-species recognition via oligosaccharides serves a function useful to both organisms involved. It is possible that such interactions are much more common and that they have not been carefully sought after.
Effects of oligosaccharides on the biological functions of proteins: 'on-off and 'riming' functions There are several examples in which glycosylation can substantially modulate the interaction of peptides with their cognate ligands or receptors (see Tables I and VI) . Some cell surface receptors for growth factors appear to acquire their binding functions in a glycosylation-dependent manner. Thus, the acquisition of function of a newly synthesized receptor may be delayed until it is well on its way to the cell surface. This might limit unwanted early interactions with a growth factor synthesized in the same cell. Glycosylation of a ligand can also potentially mediate such an 'on-off or 'switching' effect. When the hormone human /3 chorionic gonadotrophin (/3-HCG) is deglycosylated, it still binds to its receptor with similar affinity, but fails to transmit a signal via stimulation o f adenylate cyclase. Thus, an agonist is converted into an antagonist; the precise mechanism of this effect remains unknown.
In most cases, such effects of glycosylation are not all or none, but are partial, or relative. In these 'tuning' functions, the biological activity of many glycosylated growth factors or hormones appears to be modulated over a significant range by the presence and extent of glycosylation. For example, the cytokine granulocyte/macrophage colony-stimulating factor (GM-CSF) is known to be most active in the unnatural non-glycosylated form derived from recombinant technology. However, naturally occurring preparations of GM-CSF contain a range of 'glycoforms', each of which shows substantial differences in binding affinity and signal transduction (see Tables I and VI) . Another excellent example of this 'tuning' function is seen in the addition of polysialic acid to the neural cell adhesion molecule (N-CAM), which normally mediates homophilic binding with identical molecules on other cells (see Table XI ). In the embryonic form, the oligosaccharides of this protein carry extended highly anionic chains of sialic acids that markedly reduce its capacity for homophilic binding. During development, the length of these polysialic acid molecules is altered, such that in the adult state they are much shorter. Thus, the adult N-CAM is capable of more effective homophilic binding, presumably because there is no longer a need for as much plasticity in the nervous system.
In other cases, the function of proteins can be 'tuned' not by oligosaccharides on the receptors or ligands themselves, but by those on other neighbouring structures. An excellent example of this is seen in the modulation of growth factor receptors by gangliosides (see Table VI ). The gangliosides are discrete and separate entities from the receptor proteins. However, it has been well demonstrated that the precise type of ganglioside that is present in a membrane can have a substantial effect on the tyrosine phosphorylation activity of the epidermal growth factor (EGF) receptor and the insulin receptor. While the precise mechanism of these effects is uncertain and some conflicting data have been published, it is clear that the specific oligosaccharide sequence of the ganglioside is required, rather than simply its net charge or size. Likewise, the polysialic acids of embryonic N-CAM have been shown to substantially blunt the binding of apposing cells via other unrelated receptor-ligand pairs, simply by physically expanding the space between cells. An extreme example of a 'tuning' effect of an oligosaccharide on a separate protein is that in which the heparin molecule modulates the action of the natural anticoagulant antithrombin HI (see Table XI ). In this case, the binding of highly specific heparin sequence to antithrombin m converts a very weak antithrombin into a potent anticoagulant. Such heparin sequences are presumed to have a significant anu'-thrombogenic role on the surface of endothelial cells that are in contact with the blood stream.
Since these 'tuning' effects of oligosaccharides are usually partial and are rarely absolute, a sceptic might raise questions about their importance. However, when taken together, such partial effects could have a dramatic effect on the final biological outcome. Consider two different cell types that have the same number and types of growth factor receptors, and that are presented with the identical concentrations of the same growth factors. If the signal delivered to a cell was based only on the primary receptor-ligand interactions, there should be no difference in response between these two cells. However, if differences existed in the glycosylation state of the ligands, receptors or membrane gangliosides, each could have a significant positive or negative quantitative effect on the final signals delivered to the cell. Furthermore, glycosaminoglycan chains on the surface and in the matrix surrounding the cells could also modulate the action of each growth factor differently. Taken together, the combined effects on the different receptor-ligand-104 generated signals would be quite different for the two different cells. These differences would be further amplified by the fact that the intracellular signalling mechanisms of many receptors show significant overlap and cross-talk. Thus, the final effects of the same ligands at the same concentrations on the two different cells in question could be dramatically different. Thus, glycosylation can be a general mechanism for generating important functional diversity, while utilizing a limited set of receptor-ligand interactions.
As with most other functions of the oligosaccharides discussed so far, clear exceptions can be encountered. There are receptors whose ligand binding is not acquired in a glycosylation-dependent manner, and there are ligands whose binding and action is affected very little by the precise type of glycosylation found on itself or on its cognate receptor (see Table I ). Once again, it is not possible to make a generalized theory based on the specific instances studied. The 'sink' or 'depot' function of oligosaccharides Another recently appreciated function of oligosaccharides appears to be that of acting as a protective storage depot for certain biologically important molecules (see Table VII ). It has long been known that a variety of growth factors could be purified by affinity chromatography on immobilized glycosaminoglycan chains such as heparin. It now appears that the specific growth factors may bind tightly and specifically to certain glycosaminoglycan chains in vivo. This serves to localize the growth factors in question to the extracellular matrix surrounding the cells that need to be stimulated, and prevents diffusion of the factors to distal sites. There is also evidence that such a 'sink' can protect the growth factors from non-specific proteolysis, thus prolonging their active lives. A similar role may be played by the glycosaminoglycan chains found in secretory granules that appear to bind and protect protein contents after secretion, and to modulate their subsequent functions. As indicated in Table VII , there are other classic examples where oligosaccharides may act as 'sinks' or 'depots' for a variety of biological important molecules, ranging from water to complement regulatory proteins. The best understood example of such functions is the role of mannose-6-phosphate residues in targeting newly synthesized lysosomal enzymes to their final destination in the lysosomes (see Table VJLLL ). In this case, the human disease states in which phosphorylation is deficient (I-cell disease and pseudo-Hurler polydystrophy) are characterized by a failure of lysosomal enzyme targeting in several cell types. This provides conclusive evidence for the importance of the oligosaccharide modification in mediating this important pathway. However, it is notable that even this elegantly precise function of oligosaccharides appears to have its exceptions: mannose phosphate is not absolutely required for the trafficking of lysosomal enzymes in some lower eukaryotes, nor is it essential in certain cell types in mammals. As indicated in Table Vin , many other endocytic receptors that recognize specific carbohydrate sequences have been described. However their role, if any, in intracellular trafficking (i.e. during the biosynthesis of glycoconjugates) has yet to be defined.
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The role of oligosaccharides in regulating the 'clearance' or turnover' of proteins and whole cells: 'intercellular trafficking'
The effects of glycosylation on the stability of proteins to proteolysis has already been mentioned, and can presumably affect meir turnover and half-life in the single cell. In the intact animal, recognition of oligosaccharide sequences by certain receptors can result in removal of the glycoconjugate or even the whole cell from the circulation. There have been several well-documented examples of the action of such 'intercellular trafficking' receptors (see Table VOT ). Many of these interactions are highly specific for the oligosaccharide sequences recognized by the receptors, suggesting that their biological roles are equally specific. In several cases, rational meories have been put forward to explain the functions of these clearance pathways (see Table VIE ). However, to date there have been very few naturally occurring mutants in these receptors described in an intact animal. This makes it difficult to obtain definitive proof of such functions. Table LX ). The best documented examples are the 'oligosaccharins' of plants, which induce specific responses in a manner highly dependent on the structure of the sugar chain. Likewise, free high-mannose chains can have strong immunosuppressive effects in in vitro mammalian systems in a manner dependent upon the specific structure of the sugar chain. It is also likely that free heparin fragments released by certain cell types have effects on other cell types, acting perhaps via binding and intemalization. However, in most of these cases the putative receptors for these molecules have not been identified, and the mechanisms by which they work remain uncertain. Many other less well defined oligosaccharides or glycopeptides with proposed biological effects are known, and are listed in Table DC .
Role of oligosaccharides in 'cell-cell and celkmatrix recognition'
Since all cells are covered with a dense coating of sugars, it has long been predicted that oligosaccharides must be critical determinants of 'cell-cell interactions'. In actual fact, there are relatively few examples in which such functions have been clearly defined (see Table X ). Perhaps the best-documented example is that of the selectin family of receptor proteins that mediate the adhesion of leukocytes to endotheUal cells (L-selectin), the recognition of leukocytes by stimulated or wounded endothelium (E-selectin), and the interactions of activated platelets or endothelium with leukocytes (P-selectin).
In each case, the minimal carbohydrate ligands involved in recognition appear to be sialylated fucosylated sugar chains, such as sialyl Lewis" and sialyl Lewis*. However, biologically relevant recognition may require specific glycoconjugates that 'present' multiple copies of such oligosaccharides in a specialized fashion, i.e. in a proper spacing on the linear polypeptide chain, or in the proper three-dimensional context In this regard, we have recently suggested that oligosaccharides that are very closely spaced together on the polypeptide might be packed tightly together, generating a 'clustered saccharide patch' for specific recognition. This would allow the generation of uncommon recognition markers utilizing common oligosaccharides. Alternatively, specific modifications of the oligosaccharides (e.g. sulphation) might be creating unique binding sites. There is also now substantial evidence that the binding of sperm to eggs involves the Olinked oligosaccharides on the zona pellucida glycoprotein ZP3, possibly by interacting with a surface jS-galactosyltransferase. Other clear examples of cell-cell binding involving specific carbohydrates include CDw44, macrophage sialoadhesin and the B-cell lectin CD220 (see Table X ). In many of these cases, rational theories can be constructed to explain the role of these cell-cell interactions. However, with the exception of the selectins, the specific biological significance of these recognition events has not been conclusively demonstrated in the intact animal. A variation on this theme has been the proposal that carbohydrate-carbohydrate interactions may play a specific role in cell-cell interactions and adhesion. Several examples of such interactions have been presented and appear to show specificity for the structural details of oligosaccharides involved (see Table  X ). For example, there is provocative evidence that during murine embryogenesis, the stage-specific embryonic antigen (SSEA) which appears at the 16-cell stage is important in the compaction of the embryo, due to an Le*-Le* interaction. The affinities of such interactions can be measured with some difficulty and do not appear to be very strong. However, if the molecules in question are present in high copy number on the cell surface (e.g. glycolipids), the summing of a large number of relatively low-affinity interactions could result in a substantially higher avidity, sufficient for biological relevance. Such a 'velcro' effect may well be sufficient to mediate biologically relevant recognition.
In many of these cell-cell interactions, protein-protein binding phenomena clearly also play critical roles, e.g. the LFA-I/ I-CAM interaction in leukocyte-endothelium binding (87). However, these interactions appear to require activation of the cells and do not seem to work well under the shear forces present in the flowing bloodstream. Several lines of evidence indicate that oligosaccharide-protein interactions provide the initial specificity for the interaction, and the strength and permanence of the association is then mediated by proteinprotein interactions (reviewed in 87-93). This would allow the parsimonious use of a limited set of protein-protein interactions as a generic glue for a variety of cell-cell interactions, while leaving the specificity to the diversity of oligosaccharide structures.
Such intercellular interactions should be most important during embryonic development. The number of genes (50 000-100 000) available in the genome of a mouse cannot possibly account for the numerous specific steps required for complete murine embryogenesis if a different gene was required for a each step. However, a set of glycosyltransferases expressed in various combinations could provide a wide variety of different potential ligands for cell-cell interactions. The frequent demonstration of regional, spatial and gradient expression of carbohydrate structures during embryonic development strengthens the notion that such specific interactions are indeed important at various steps in development However, proof that such interactions are important requires the availability of mutants with genetic defects in glycosylation.
Do any general principles emerge?
The discussion so far makes it clear that the oligosaccharide units of glycoconjugates have many and varied functions. It also leads to the conclusion that while all of the theories about their functions appear to be correct, exceptions to each can also be found. A corollary of this conclusion is that it is difficult to predict a priori the functions of a given oligosaccharide on a given glycoconjugate. Fortunately, some other worthwhile principles do emerge from this analysis.
Temporal and spatial differences in the expression of oHgosaccharides: the same structure can have multiple roles
The expression of specific types of glycosylation on different gryconjugates in different tissues at different times of development implies that these structures must have diverse and different roles in the same organism. For example, mannose-6-phosphate-containing oligosaccharides were first described on lysosomal enzymes and are clearly involved in targeting them to lysosomes. However, since that time, mannose-6-phosphate-containing oligosaccharides have been found on a variety of apparently unrelated proteins, including proliferin (1038), thyroglobulin (947, 948), the EGF receptor (1039) and the transforming growth factor £ (TGF-0) precursor (895). While the significance of these observations is uncertain, they raise the possibility that mannose-6-phosphate-containing oligosaccharides have other biological roles. Likewise, the sialylated fucosylated lactosamines critical for recognition by the selectins are also found in variety of other tissues, where the selectins are unlikely to be functioning (16, 17) . The polysialic acid chains that appear to play such an important role in embryonic N-CAM have also been found on proteins as diverse as an egg jelly coat protein and a sodium channel protein (18). Likewise, 9-O-acetylation of sialic acids is found on a variety of different glycoconjugates, in a variety of different tissues at different times in development (7, 74, 76) .
Given that oligosaccharides are post-translational modifications, these observations should not be entirely surprising. Once it is expressed in an organism, the same oligosaccharide modification could have independently evolved several distinct usages in different tissues and at different times in development. If any one of these functions were vital to the survival of the organism, then the transferase mediating the expression of the oligosaccharide structure would be conserved in evolution, thus perpetuating the less important situations where it was expressed as well. It is even conceivable that expression of a particular structure on a particular glycoconjugate might be of no positive consequence whatsoever in that particular situation. However, the transferase responsible for this structure may have been selected because of its vital contribution to the function of an entirely different glycoconjugate. As long as there was no strongly negative consequence for the first glycoconjugate, its expression might persist in that situation and be considered 'revenue neutral' for the organism.
Can the interplay between traitorous' and 'masking' functions result in the formation of 'junk' oligosaccharides?
The 9-0-acetylester group that abrogates binding of the highly pathogenic influenza A viruses to sialic acids simultaneously generates a specific binding site for the less pathogenic influenza C virus and coronaviruses (see Tables IV and V) . Such 0-acetylated acids are frequently found on mucosal surfaces of mammals Perhaps the mammalian organism first attempted to mask the sialic acid receptor for the highly pathogenic influenza A virus by adding an O-acetyl group to it. However, subsequent selection could have resulted in the appearance of microorganisms (influenza C and coronaviruses) capable of binding specifically to the 'masking' structure.
Since microorganisms and parasites evolved in parallel with their multicellular hosts, they may have had to constantly adapt themselves to bind to each new 'masking' structure evolved by the host. In response, the host organism may have found it most efficient to generate new masking structures, perhaps because the existing structure had already evolved a vital function elsewhere within the organism. Having committed itself to this course of action, the host would then be left with no choice but to keep the underlying 'scaffolding' upon which the latest 'mask' was placed. Thus, yet another layer of complexity would have been added to its oligosaccharides. Such cycles of interaction between microorganisms and hosts could explain in part some of the extremely complex and extended sugar chains found on mucosal surfaces and secreted mucins. It also leads to the possibility that 'junk' oligosaccharides do exist akin to 'junk' DNA. While serving a general (and important) function as a scaffolding, they may have no other specific definable role.
Inter-species variations in glycosylation
The existence of species-specific variations in glycoconjugate structure indicates that some oligosaccharides do not play fundamental and universal roles in all biological systems. For example, the glycolipids of red blood cells from various mammalian species show striking differences both in the primary sequence of the glyconjugate and in the type of sialic acid on the acidic glycolipids (see Table XII ). Likewise, when the ^-linked glycosylation on a conserved protein such as gamma ghitamyl transpeptidase was examined from a variety of species, marked differences were seen in the sequence of the sugar chains (35). Such variations between species in the glycosylation of similar proteins or cells imply that these sugar chains cannot be crucial for the basic functions of these proteins or cells. On the other hand, such diversity in glycosylation could certainly be involved in generating the many obvious differences in morphology and function that are observed between species. Such differences could also reflect differing selection pressures resulting from different pathogens that infect the different species.
Intra-species variations in glycosylation
Genetic polymorphisms with no known biological consequence are quite common in proteins. For example, in Sweden alone, at least nine different albumin variants were found, with a combined prevalence of 1:1700 in the population (1046) . The genetic polymorphisms in glycosylation diat are recogruzed as 'blood-groups' (discovered because of the unnatural practice of blood transfusion) also have limited consequences for the normal biology of humans. Similar intra-species polymorphisms have been observed between the sialic acids on red blood cells or hepatocytes in different in-bred strains of mice and dogs (see Table XII ). It is clear that substantial intra-species polymorphism in oligosaccharide structure can exist without obvious reason. However, these polymorphisms may be of far more importance in the wild state, where protection against certain microorganisms or other noxious agents could prove to be of survival value to a segment of the population expressing a specific oligosaccharide structure. In some cases, the pathogens that originally selected for such polymorphisms may have disappeared from the environment in the very recent evolutionary past, leaving behind the unexplained polymorphism. Terminal sequences, unusual structures and modifications of oligosaccharides are more likely to mediate specific biological roles
It is reasonably clear that the biological roles of oligosaccharides can range from those that are trivial to those that are critical for the development, growth, function or survival of an organism. The challenge then is to predict which sugar chains are likely to mediate the more specific or crucial biological roles. Review of the matter suggests that terminal sugar sequences, unusual structures or modifications of the oligosaccharides are more likely to be involved in such specific roles (see Table XI ). For example, the high-mannose oligosaccharide structures of lysosomal enzymes are identical to diose found on a wide variety of proteins, ranging from the immunoglobulin IgM in nrmrpmal<: to the lectin soybean agglutinin in plants. It is reasonable to suggest tiiat such a widely expressed structure is less likely to be involved in mediating specific biological functions. On the other hand, the addition of phosphomonester residues to one or two of the mannose units results in the generation of the highly specific phosphomannosyl recognition marker that dictates trafficking of die enzyme to the lysosome. Likewise, segments of the common heparin/heparan disaccharide repeating unit are converted into specific ligands for antithrombin HI or basic fibroblast growth factor (bFGF) by a highly ordered series of epimerizanon and sulphation reactions. Similar, although less conclusive arguments can be made for other modifications such as polysialic acids, O-acetylation of sialic acids, polylactosaminoglycan chain formation and outer chain fucosylation (see Table XI ). Unusual oligosaccharides or modifications are also more likely to arise from interactions with microorganisms and other noxious agents
The constant balance between the 'traitorous' and 'masking' functions of oUgosaccharides has been discussed above (see Tables IV and V) . In most cases, it is the terminal or outer sugars and their modifications that are involved in these lifeand-death interactions. Consequently, while such structures may be more involved in specific biological roles within the organism, they are also most likely to vary as a result of host-pathogen interactions. However, the two functions need not be mutually exclusive. For example, it is possible that while O-acetylation of sialic acids on mucosal surfaces may play a protective role in host-microbial interaction, the temporal and spatial gradients of expression of O-acetylation found in the developing nervous system may play important roles in the process of development in the brain. The challenge then is to predict and sort out which of these two completely distinct roles are to be assigned to a given oligosaccharide structure. In some cases of sporadic autoimmune reactions to oligosaccharides, the antigenic structures are normally present in adult tissues (e.g. antibodies against peripheral nerve glycolipids seen in some individuals with multiple myeloma). However, there are examples of oligosaccharide structures which when expressed postnatally by the organism result universally in an immune response. The best examples in humans are the conversion of A/-acetylneuraniinic acid to iV-glycolylneuraminic acid (1040, 1041) and the expression of Galal-3 Gal sequences (see Table XH ). In these cases, the structures are not expressed in normal adults, but can appear in disease states such as cancer, resulting in immune reactions due to newly induced or pre-existing antibodies. In at least one case (N-glycolylneuraminic acid), it is clear that expression actually does occur in the normal fetus, but is then suppressed postnatally in the normal adult. The oligosaccharides in question evidently must have no normal functions in the adult. However, it is likely that their expression in the fetus is a required event and is a case of ontogeny recapitulating phytogeny.
Is there a common theme to the varied functions of oligosaccharides?
We have reviewed the evidence that all of the diverse theories regarding the functions of oligosaccharides are correct, but that exceptions to almost every theory can also be found. In the final analysis, the only common feature of all of these functions is that they either mediate 'specific recognition' events or that they provide 'modulation' of biological processes. In so doing, they help to generate the functional diversity that is required for the evolution and development of different types of cells, tissues, organs and species. There is a limited number of genes available in the genome for the generation of such diversity. Thus, it should not be surprising that an oligosaccharide structure resulting from the action of a single gene product could be utilized to generate a wide variety of functions in different tissues at different times in the life cycle of the organism. However, even complete knowledge about the structure, biosynthesis and expression of a particular type of structure does not necessarily give us clues to its specific functions. The challenge before us is to design experiments to differentiate between the trivial and crucial functions mediated by a given oligosaccharide.
Approaches to uncovering specific biological roles of oligosaccharides Some functions of oligosaccharides are discovered serendipitously. In most cases, the investigator who has elucidated complete details of the structure and biosynthesis of a specific oligosaccharide is still left without knowing its functions. If it is possible to make educated guesses about the role of the oligosaccharide in question, this can sometimes lead to definitive experiments. However, conclusive proof of the biological roles of an oligosaccharide sequence often requires analysis of mutants that are defective in such a structure. It is therefore useful to consider the lessons that have been learned to date by studying such mutants. Mutants affecting the biosynthesis of dolichol sugars, sugar nucleotides or sugar nucleotide transport into the Golgi apparatus have also been obtained, and have pleiotropic effects on the biosynthesis of multiple types of glycoconjugates in the same cell. Likewise, cell lines can be grown in the presence of global inhibitors of the biosynthesis and processing of several types of oligosaccharides (for example, see 1042). In most of these situations, the abnormalities in glycosylation seem to have limited consequences to the growth and maintenance of these tissue culture cell lines. This suggests that many (though not all) aspects of glycosylation are of limited importance in the day-today housekeeping functions of the single cell, when it is in a protected environment, under optimal conditions of growth. Of note, however, some of these mutants do show alterations in density-dependent growth inhibition and others demonstrate changes in tumorigenicity or metastatic behaviour when injected into athymic mice (1045) . This suggests that many of the more specific biological roles of oligosaccharides need to be uncovered by studying mutations in the intact multicellular organism.
Genetic defects in glycosylation are rare in intact organisms, but have highly variable consequences In contrast to the situation in vitro, genetic defects in glycosylation are surprisingly rare in intact organisms. There are few other biochemical pathways in which naturally occurring mutants in mouse and man are so uncommon. In the few instances in which glycosylation mutants have been observed in intact complex multicellular organisms, the consequences have been highly variable (see Table XII ). In humans, the effects of genetically altered glycosylation range from severe lethal diseases such as I-cell disease to apparently unremarkable consequences such the ABO blood group polymorphisms. Glycosylation mutants in intact mice are even more uncommon. The rarity of such naturally occurring mutations could be explained in several ways. It is possible that they do occur frequently, but have little detectable biological consequence. A more likely possibility is that the great majority of them cause lethal aberrations that prevent completion of embryogenesis. A third possibility is that mutations in glycosylation remain undetected because of alternate or 'fail-safe' mechanisms that ensure that vital biological functions are carried out by more than one pathway. In this regard, it is worth noting that the congenital absence of a variety of highly conserved proteins in humans (e.g. glycophorin A, haptoglobin, prekallikrein, myeloperoxidase, coagulation factor XII and high molecular weight kininogen) are also known to have little biological or pathological consequence. Likewise, many 'knockout' experiments involving highly conserved proteins such as cellular proto-oncogenes have surprisingly limited consequences in the intact mouse (1047, 1049) .
Creating mutants in glycosylation in intact organisms: a challenge for the future To explore these issues, it appears necessary to create mutants in glycosylation in intact animals. Several possible approaches could be taken towards this goal. Antibodies or lectins specific for certain oligosaccharide sequences could be expressed in transgenic animals or injected into specific developing tissues. However, since such molecules are multivalent, they may disrupt development or other functions simply by causing unwanted cell-cell adhesion. Alternatively, the molecular cloning of glycosyltransferases allows overexpression, or the creation of 'knockout' mice lacking a specific sugar sequence. If such an intervention blocks early embryogenesis, the consequences may not be available for analysis (study of firstgeneration chimeric animals may give some information in gene-deletion experiments). However, even if live homozygous animals are observed with overexpression or with gene deletions, care must be taken in interpreting the results. The consequences seen could be the result of interference with other competing glycosylation pathways, or may be due to nonspecific physical effects of grossly altered glycosylation in all tissues of the organism.
An alternate approach makes use of the fact that many microbial degradative enzymes are highly specific for certain outer sugar chain sequences. Thus, direct injection of specific endoneuraminidase into developing neural tissues yielded dramatic phenotypic changes (901, 905), suggesting specific roles for polysialic acids, and injection of heparanase into the developing embryo caused randomization of left-right axis formation (1048) . Expression in transgenic mice of a viral sialic acid-specific 9-O-acetylesterase under the control of specific promoters caused abnormalities either early or late in development (940). In principle, the latter approach could be generalized to any situation where a cDNA is available encoding a specific oligosaccharide-degrading enzyme. Thus, rather than interfering with the basic genetic and cellular machinery responsible for the synthesis of specific oligosaccharides, one might eliminate them selectively after normal synthesis by expression of a degradative enzyme as a cell surface molecule. Specific promoters should limit expression of the enzyme and allow the analysis of tissue-specific functions of oligosaccharides in later stages of development, side-stepping an early lethal event that could have occurred with a gene 'knockout' experiment. In the short term, such approaches are likely to generate even more new questions than immediate answers. However, it is much better to have many incomplete clues to the biological roles of oligosaccharides than to have extensive and specific structural information only, and no way to pursue their relevance.
Future prospects
As recently suggested, modern progress in glycobiology 'has finally opened a crack in the door to one of the last great frontiers of biochemistry' (36). The future now appears bright for the understanding of many new biological roles of oligosaccharides. Until recently, mainstream research was focused either on the molecular biology of the single cell, or on the physiology of whole organs or organisms. In both of these disparate areas, the roles of oligosaccharides tend to be less prominent and can often be ignored or bypassed. However, the future of biology and biotechnology now lies in studies of cell-cell interactions, embryonic development, tissue organization and morphogenesis, and in the integration of these studies with the molecular physiology and pharmacology of organs and organisms. In these arenas, the biological roles of oligosaccharides seem to be critical and their understanding becomes crucial to further progress. 
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